The TEU-H83 is a fully automatic high-speed rotary tablet press engineered for high-volume double-layer (bi-layer) pharmaceutical tablet production. Featuring 83 BB-type punch stations generating 358,560 tablets per hour, this machine delivers the highest throughput in its class while maintaining precision weight and hardness control across both layers. It is the production workhorse for large-scale pharmaceutical manufacturers requiring maximum output for combination tablets products, controlled-release formulations, and nutraceutical bi-layer tablets.
Equipped with dual independent force-feeding systems, advanced automatic weight control (AWC), 100kN main compression, and fully enclosed dust-free cabin, the TEU-H83 combines uncompromising productivity with cGMP and FDA 21 CFR Part 11 compliance. The quick-disassembly sanitary design of all product contact parts enables efficient cleaning and rapid product changeover between campaigns, maximizing equipment utilization in 24/7 production environments.
Frequently Asked Questions
Q1: What is the actual production capacity of the TEU-H83 for double-layer tablets?
A: The TEU-H83 produces up to 358,560 tablets per hour for standard round tablets. For double-layer tablets, actual output depends on formulation characteristics, but typically ranges from 280,000-350,000 tablets per hour under normal production conditions.
Q2: How does the double-layer compression process work?
A: The first layer powder is filled and lightly pre-compressed to form the base layer while maintaining a rough surface for bonding. The second layer powder is then filled on top, and both layers undergo final main compression at 100kN, creating a single integrated bi-layer tablet with a clearly defined separation line.
Q3: Can this machine also produce single-layer tablets?
A: Yes. The TEU-H83 switches between double-layer and single-layer production via HMI parameter adjustment. For single-layer runs, the second feeding station is deactivated and output can reach even higher speeds using all 83 stations.
Q4: What is the typical ROI timeline?
A: With 358,560 tablets per hour output, a single 8-hour shift produces approximately 2.8 million tablets daily. Most contract manufacturers achieve full ROI within 12-18 months, while captive pharma plants typically recover investment within 2-3 years through reduced labor and increased throughput.
Q5: How does the AWC system maintain precision at high speed?
A: The AWC system samples compression force at every station in real-time. When deviation from set tolerances is detected, the PLC immediately adjusts the filling cam position. The system also supports individual first-layer weight sampling during production, ensuring both layers remain within specification without stopping the machine.
Q6: Is the control system FDA 21 CFR Part 11 compliant?
A: Yes. The German PLC and HMI provide multi-level user access, electronic signatures, comprehensive audit trails, secure data logging, and recipe management with full version history. Validation documentation is included in the standard delivery package.
Q7: What tooling options are available?
A: The TEU-H83 uses BB-type tooling (19mm shaft, 24mm die). We custom-manufacture punches and dies in round, oblong, capsule, geometric shapes with embossing, scoring, and logo options. Wear-resistant coatings (TiN, CrN) are available for abrasive formulations.
Q8: What after-sales support is included?
A: We provide complete IQ/OQ/PQ documentation, on-site installation and commissioning, operator training (3-5 days), preventive maintenance schedules, recommended spare parts inventory lists, 24/7 remote technical support, and worldwide spare parts shipping.